Bio-Rad Laboratories, Inc. BIO.B
Set alert
379.50 USD 0.00 0.00%
At close · Oct 30
387.21 +7.71 +2.03%
After hours · Oct 30, 4:10 PM ET
379.50 Day range 379.50
255.54 52-week range 379.50
- YTD
- +22.14%
- 1 year
- +25.19%
- Open
- 379.50
- Prev close
- 379.50
- Mkt cap
- 10.16B
- Vol
- 14
- Avg vol
- 9
- EPS
- 7.89
- P/E
- 48.10
- Div yield
- 0.00%
More statistics
- Low
- 379.50
- High
- 379.50
- Forward P/E
- 33.78
- Beta
- 1.08
- Short ratio
- 0.00
- Inst. own
- 0.08%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 288.90
- 200-d avg
- 292.78
- 1y target
- 0.00
Financial health
Piotroski F-Score
7 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-3 / 5 overall
- DCF 3
- Return on Equity 2
- Return on Assets 1
- Debt / Equity 3
- P/E 2
- P/B 4
Valuation
P/E 10.9×
FY 2016 5y median -3.5× FY 2025
P/S 3.2×
FY 2016 5y median 3.6× FY 2025
P/B 1.1×
FY 2016 5y median 1.3× FY 2025
P/FCF 22.1×
FY 2016 5y median 42.1× FY 2025
EV/EBITDA 7.7×
FY 2016 5y median -3.0× FY 2025
EV/Sales 3.6×
FY 2016 5y median 4.0× FY 2025
FCF Yield 4.5%
FY 2016 5y median 2.4% FY 2025
Profitability
Gross Margin 52.0%
FY 2016 5y median 53.7% FY 2025
Operating Margin 10.5%
FY 2016 5y median 12.6% FY 2025
Net Margin 29.4%
FY 2016 5y median -23.9% FY 2025
ROE 10.2%
FY 2016 5y median -7.3% FY 2025
ROIC 2.0%
FY 2016 5y median 2.3% FY 2025
ROA 7.2%
FY 2016 5y median -5.2% FY 2025
Growth (YoY)
Revenue 0.7%
FY 2016 FY 2025
Operating Income 0.6%
FY 2016 FY 2025
EPS (diluted) 142.6%
FY 2016 FY 2025
Free Cash Flow 40.7%
FY 2016 FY 2025
Financial Health
Current Ratio 5.6×
FY 2016 5y median 5.6× FY 2025
Quick Ratio 4.2×
FY 2016 5y median 4.3× FY 2025
Debt / Equity 0.2×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA 0.8×
FY 2016 5y median -0.2× FY 2025
Interest Coverage 5.5×
FY 2016 5y median 6.8× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31